We further demonstrated that SIRT7 promoted repigmentation of melanocytes by mediating G6PD, suggesting that SIRT7‐mediated desuccinylation of G6PD promotes the progression of vitiligo disease, and more importantly, the specific downregulation of SIRT7 might be a promising target for vitiligo therapy. The gene discussed is G6PD; the disease is vitiligo.